Results 11 to 20 of about 2,986,872 (249)
Changing healthcare organisations to change clinical performance [PDF]
Medical Journal of Australia, 2004 We propose the formation of evidence-based clinical practice support units in hospitals and clinical research implementation networks. The purpose of these initiatives will be to increase the uptake of beneficial forms of care and remove harmful or ineffective practices.
Robinson, J., Turnbull, D.
openaire +3 more sources
Wellcome Open Research, 2023 Background: The Behaviour Change Technique Taxonomy v1 (BCTTv1) specifies the potentially active content of behaviour change interventions. Evaluation of BCTTv1 showed the need to extend it into a formal ontology, improve its labels and definitions, add ...
Robert West +7 more
doaj +1 more source
Improving service provision through change management
South African Family Practice, 2023 The change agent role of the family physician is often a daunting task with very little guidance on how to approach change leadership in the current fellowship curriculum.
Mergan Naidoo
doaj +1 more source
Pilot and Feasibility Studies, 2018 Background Many people living with cardiovascular disease (CVD) are affected by sexual problems associated with the condition. International guidelines recommend all patients with CVD should receive sexual counselling, yet this is rarely provided by ...
Patrick J. Murphy +15 more
doaj +1 more source
Change process in psychotherapy for criminal offenders: a comprehensive review with content analysis
Frontiers in PsychologyThe aim of this study is to systematically identify and synthesise the therapeutic components that facilitate recovery in criminal offenders undergoing psychotherapy or psychosocial interventions.
Nihal Tutal +3 more
doaj +1 more source
AnimalsRadiation therapy is a crucial cancer treatment, but it can damage healthy tissues, leading to side effects like skin injuries and molecular alterations.
Sang-Yun Lee +10 more
doaj +1 more source
Dabigatran: Will it change clinical practice?
Cleveland Clinic Journal of Medicine, 2011 Dabigatran (Pradaxa) is a new oral anticoagulant approved in the United States for the primary prevention of stroke and systemic embolization in patients with nonvalvular atrial fibrillation. It offers clinicians an alternative to warfarin (Coumadin), and it has received considerable interest because of its convenience of use, clinical efficacy, and ...
Siddharth A, Wartak, John R, Bartholomew
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele +19 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu +8 more
wiley +1 more source